Skip to main content
. Author manuscript; available in PMC: 2025 Aug 26.
Published in final edited form as: J Nutr Health Aging. 2024 Jul 26;28(9):100317. doi: 10.1016/j.jnha.2024.100317

Table 2.

Associations between the change in performance measures and blood pressure after sequential covariate adjustment.

Outcomes
Systolic blood pressure
β (95% CI)
Diastolic blood pressure
β (95% CI)
Model 1
 Grip strength 0.88 (0.37, 1.40) 0.69 (0.39, 0.98)
 Chair stand 0.22 (−0.02, 0.47) 0.07 (−0.03, 0.17)
 Gait speed 0.61 (0.12, 1.10) 0.71 (0.42, 0.99)
Model 2
 Grip strength 0.62 (0.09, 1.15) 0.41 (0.10, 0.71)
 Chair stand 0.18 (−0.04, 0.40) 0.01 (−0.05, 0.07)
 Gait speed 0.78 (0.26, 1.30) 0.59 (0.28, 0.90)
Model 3
 Grip strength 0.59 (0.06, 1.11) 0.35 (0.04, 0.65)
 Chair stand 0.17 (−0.05, 0.38) 0.00 (−0.06, 0.06)
 Gait speed 0.74 (0.22, 1.26) 0.55 (0.24, 0.85)

Notes:

*

point estimates express the association between one standardized unit change in each performance measure and the associated BP change.

Significance

p<0.05;

p<0.01;

p<0.0001.

Model 1: age, race and ethnicity, clinic site, education.

Model 2: Model 1+ smoking status, alcohol use, cognitive function (Teng 3MS), self-rated health (SF12), time-varying physical activity (PASE score) and BMI (calculated using data from baseline, year 7 and 9 follow-up time points), prior fall, presence of at least one comorbidity (yes/no, osteoarthritis, COPD, kidney disease/failure, diabetes).

Model 3: Model 2 + CVD + time-varying duration of antihypertensive medication usage (calculated as the maximum value of a duration at each time point).